[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![BowTiedBiotech Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1462941795520638981.png) BowTiedBiotech 🧪🔬🧬 [@BowTiedBiotech](/creator/twitter/BowTiedBiotech) on x 19.7K followers
Created: 2025-03-30 02:23:07 UTC

#1 Biotech in Europe?

🇪🇺 $ARGX - Argenx leads the pack with a $35B market cap

That’s ahead of some big-name U.S. biotechs:
🔹$ALNY (Alnylam) - ~$34B
🔹$IONS (Ionis) - ~$5B
🔹$BBIO (BridgeBio) - ~$6B
🔹$BEAM (Beam) - ~$2B

$ARGX > $IONS + $Beam + $BBIO COMBINED
Seriously.

The engine?
🧬 Vyvgart - an FcRn inhibitor turning into a multi-indication autoimmune franchise
CIDP, ITP, MG, and more on deck.

Could $ARGX become Europe’s Regeneron?

![](https://pbs.twimg.com/media/GnQTx9EWQAAUJhb.jpg)

XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1906170295058141692/c:line.svg)

**Related Topics**
[market cap](/topic/market-cap)
[$mngl](/topic/$mngl)
[$2b](/topic/$2b)
[$6b](/topic/$6b)
[$5b](/topic/$5b)
[$34b](/topic/$34b)
[$alny](/topic/$alny)
[$35b](/topic/$35b)

[Post Link](https://x.com/BowTiedBiotech/status/1906170295058141692)